Literature DB >> 29553569

Titration ELISA as a Method to Determine the Dissociation Constant of Receptor Ligand Interaction.

Johannes A Eble1.   

Abstract

The dissociation constant describes the interaction between two partners in the binding equilibrium and is a measure of their affinity. It is a crucial parameter to compare different ligands, e.g., competitive inhibitors, protein isoforms and mutants, for their binding strength to a binding partner. Dissociation constants are determined by plotting concentrations of bound versus free ligand as binding curves. In contrast, titration curves, in which a signal that is proportional to the concentration of bound ligand is plotted against the total concentration of added ligand, are much easier to record. The signal can be detected spectroscopically and by enzyme-linked immunosorbent assay (ELISA). This is exemplified in a protocol for a titration ELISA that measures the binding of the snake venom-derived rhodocetin to its immobilized target domain of α2β1 integrin. Titration ELISAs are versatile and widely used. Any pair of interacting proteins can be used as immobilized receptor and soluble ligand, provided that both proteins are pure, and their concentrations are known. The difficulty so far has been to determine the dissociation constant from a titration curve. In this study, a mathematical function underlying titration curves is introduced. Without any error-prone graphical estimation of a saturation yield, this algorithm allows processing of the raw data (signal intensities at different concentrations of added ligand) directly by mathematical evaluation via non-linear regression. Thus, several titration curves can be recorded simultaneously and transformed into a set of characteristic parameters, among them the dissociation constant and the concentration of binding-active receptor, and they can be evaluated statistically. When combined with this algorithm, titration ELISAs gain the advantage of directly presenting the dissociation constant. Therefore, they may be used more efficiently in the future.

Mesh:

Substances:

Year:  2018        PMID: 29553569      PMCID: PMC5912426          DOI: 10.3791/57334

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  25 in total

Review 1.  Surface plasmon resonance: towards an understanding of the mechanisms of biological molecular recognition.

Authors:  J M McDonnell
Journal:  Curr Opin Chem Biol       Date:  2001-10       Impact factor: 8.822

Review 2.  NMR methods for the determination of protein-ligand dissociation constants.

Authors:  Lee Fielding
Journal:  Curr Top Med Chem       Date:  2003       Impact factor: 3.295

3.  The alpha2beta1 integrin inhibitor rhodocetin binds to the A-domain of the integrin alpha2 subunit proximal to the collagen-binding site.

Authors:  Johannes A Eble; Danny S Tuckwell
Journal:  Biochem J       Date:  2003-11-15       Impact factor: 3.857

4.  Protein-protein binding affinities by pulse proteolysis: application to TEM-1/BLIP protein complexes.

Authors:  Melinda S Hanes; Kathleen Ratcliff; Susan Marqusee; Tracy M Handel
Journal:  Protein Sci       Date:  2010-10       Impact factor: 6.725

5.  The application of the law of mass action to binding by proteins; interactions with calcium.

Authors:  I M KLOTZ
Journal:  Arch Biochem       Date:  1946-01

6.  Real-time monitoring and kinetic parameter estimation of the affinity interaction of jArtinM and rArtinM with peroxidase glycoprotein by the electrogravimetric technique.

Authors:  N C Pesquero; M M Pedroso; A M Watanabe; M H S Goldman; R C Faria; M C Roque-Barreira; P R Bueno
Journal:  Biosens Bioelectron       Date:  2010-05-07       Impact factor: 10.618

Review 7.  The collagen family.

Authors:  Sylvie Ricard-Blum
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

8.  Monoclonal antibodies reveal the alteration of the rhodocetin structure upon α2β1 integrin binding.

Authors:  Thilo Bracht; Flávia Figueiredo de Rezende; Jörg Stetefeld; Lydia M Sorokin; Johannes A Eble
Journal:  Biochem J       Date:  2011-11-15       Impact factor: 3.857

Review 9.  Integrin structure, activation, and interactions.

Authors:  Iain D Campbell; Martin J Humphries
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-03-01       Impact factor: 10.005

10.  Dramatic and concerted conformational changes enable rhodocetin to block α2β1 integrin selectively.

Authors:  Johannes A Eble; Matthew McDougall; George L Orriss; Stephan Niland; Benjamin Johanningmeier; Gottfried Pohlentz; Markus Meier; Simone Karrasch; Maria Inacia Estevão-Costa; Augusto Martins Lima; Jörg Stetefeld
Journal:  PLoS Biol       Date:  2017-07-13       Impact factor: 8.029

View more
  5 in total

1.  Improved Characteristics of RANKL Immuno-PET Imaging Using Radiolabeled Antibody Fab Fragments.

Authors:  Jonatan Dewulf; Ivanna Hrynchak; Sarah Geudens; Isabel Pintelon; Christel Vangestel; José Sereno; Peter A van Dam; Antero J Abrunhosa; Filipe Elvas; Tim Van den Wyngaert
Journal:  Pharmaceutics       Date:  2022-04-26       Impact factor: 6.525

2.  Human Hexa-Histidine-Tagged Single-Chain Variable Fragments for Bioimaging of Bacterial Infections.

Authors:  Thae Thae Min; Montarop Yamabhai
Journal:  ACS Omega       Date:  2020-12-22

3.  Generation of Multivalent Nanobody-Based Proteins with Improved Neutralization of Long α-Neurotoxins from Elapid Snakes.

Authors:  Jack Wade; Charlotte Rimbault; Hanif Ali; Line Ledsgaard; Esperanza Rivera-de-Torre; Maher Abou Hachem; Kim Boddum; Nadia Mirza; Markus-Frederik Bohn; Siri A Sakya; Fulgencio Ruso-Julve; Jan Terje Andersen; Andreas H Laustsen
Journal:  Bioconjug Chem       Date:  2022-07-23       Impact factor: 6.069

4.  Structure-Activity Relationship of the Dimeric and Oligomeric Forms of a Cytotoxic Biotherapeutic Based on Diphtheria Toxin.

Authors:  Marcin Mielecki; Marcin Ziemniak; Magdalena Ozga; Radosław Borowski; Jarosław Antosik; Angelika Kaczyńska; Beata Pająk
Journal:  Biomolecules       Date:  2022-08-12

5.  VSTM2A suppresses colorectal cancer and antagonizes Wnt signaling receptor LRP6.

Authors:  Yujuan Dong; Yanquan Zhang; Wei Kang; Guoping Wang; Huarong Chen; Akira Higashimori; Geicho Nakatsu; Minnie Go; Joanna Hm Tong; Shu Zheng; Ka Fai To; Joseph Jy Sung; Xiaoyong Yang; Simon Sm Ng; Jun Yu
Journal:  Theranostics       Date:  2019-08-21       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.